Home › NDC Lookup › Ingredients › Bismuth Subsalicylate › 82706-0028-01
💊image loading
(from DailyMed)

FEVIA Diarrhea Control Bismuth Subsalicylate 262 mg Capsule, Liquid Filled, 48-count — NDC 82706-028-01 (Billing 82706-0028-01)

by VIVUNT PHARMA LLC · 1 BOTTLE in 1 CARTON / 48 CAPSULE, LIQUID FILLED in 1 BOTTLE

This is a package of 48 capsules of FEVIA Diarrhea Control Bismuth Subsalicylate 262 mg Capsule, Liquid Filled from VIVUNT PHARMA LLC, marketed since Feb 2026 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 82706-0028-01
🏷️ FDA NDC (as labeled) 82706-028-01 billing pads the product segment with a zero
This package
Contains48-count Pack sizes2 compare ↓
Main listing for product 82706-028 · Also comes in: 24 capsules 82706-028-02
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 82706-028-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
82706 labeler · 028 product · 01 package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8270602801 5
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 82706-028-01
Product NDC 82706-028
11-digit billing NDC 82706002801
RxCUI 2121072
UNII 62TEY51RR1
Application # M008
SPL Set ID 4b20f189-e979-8198-e063-6294a90a7169
Established class (EPC) Bismuth
Chemical class Bismuth
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-02-18
Route ORAL
Dosage form CAPSULE, LIQUID FILLED
Substance BISMUTH SUBSALICYLATE
Quick answers
  • RxCUI (RxNorm): 2121072
Why two NDCs? The FDA registers this code as 82706-028-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 82706-0028-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Bismuth class.

Pharmacologic class Bismuth
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It relieves diarrhea, including traveler's diarrhea. It also helps with upset stomach after overindulging in food and drink, such as heartburn, indigestion, nausea, gas, belching a...
  • Use it only until the diarrhea stops, and no more than 2 days. If you're not better by then, or you get worse sooner, stop and see a doctor. Drink plenty of clear fluids while you...
  • That's a known, temporary and harmless effect of this medicine. But black stool can also signal bleeding, so do not use it if you already have bloody or black stool.
  • Children under 12 should be checked by a doctor first. Children and teens who have or are recovering from chicken pox or flu-like symptoms should not use it because of Reye's syndr...
📖 Read our full Bismuth Subsalicylate guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 24 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
82706-0028-02 82706-028-02 1 BOTTLE in 1 CARTON / 24 CAPSULE, LIQUID FILLED in 1 BOTTLE 2026-02-18 — Active
82706-0028-01 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 48 CAPSULE, LIQUID FILLED in 1 BOTTLE 2026-02-18 — Active

Pack size FAQ

What quantity is in this package?
This is a 48-count package — 1 bottle in 1 carton / 48 capsule, liquid filled in 1 bottle.
How does this package differ from NDC 82706-0028-02?
Both are FEVIA Diarrhea Control Bismuth Subsalicylate 262 mg Capsule, Liquid Filled — the drug itself is identical. This page's package is the 48-count one, while NDC 82706-0028-02 is the 24 capsules package.
What NDC number is used to bill for this package of FEVIA Diarrhea Control Bismuth Subsalicylate 262 mg Capsule, Liquid Filled?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bismuth subsalicylate 262 mg 35916-0234-01 Softgel 10 capsules — — FDA listed —
Pepto Bismol Liquicaps 262 mg 37000-0535-12 The 12 capsules — — FDA listed —
Pepto Bismol Diarrhea Liquicaps 262 mg 37000-0537-12 The 12 capsules — — Discontinued —
CVS Health Stomach Relief SOFTGEL 262 mg 51316-0829-22 CVS 12 capsules — — FDA listed —
RIGHT REMEDIES Stomach Relief BISMUTH SUBSALICYLATE 262 mg softgel 70692-0829-84 Strive 48 capsules — — FDA listed —
Upset Stomach Relief-Bismuth Subsalicylate 262 mg 72090-0053-01 Pioneer 48 capsules — — FDA listed —
FEVIA Diarrhea Control 262 mgthis 82706-0028-01 VIVUNT 48 capsules — — FDA listed —
Stomach Relief 262 mg 83059-0026-08 Shield 8 capsules — — Discontinued —
Stomach Relief 262 mg 83059-0111-08 Shield 8 capsules — — Discontinued —
Upset Stomach Relief-Bismuth Subsalicylate 262 mg 84324-0028-01 NUVICARE 30 capsules — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Feb 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Bismuth Subsalicylate inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerVIVUNT PHARMA LLC
FDA applicationM008 (OTC MONOGRAPH DRUG)
Labeler code82706
First marketedFeb 2026
Product typeHuman Otc Drug
Portfolio28 products on file

More NDCs from VIVUNT PHARMA LLC labeler code 82706

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 21 words ▾

Uses Relieves: traveler´s diarrhea diarrhea upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching fullness

⏱️ Dosage and Administration 82 words ▾

Directions swallow with water, do not chew adults and children 12 years and over: 2 softgels every 1/2 hour or 4 softgels every hour as needed for diarrhea 2 softgels every 1/2 hour to 1 hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea) do not exceed 16 softgels in 24 hours use until diarrhea stops but no more than 2 days children under 12 years: ask a doctor drink plenty of clear fluids to help revent dehydration caused by diarrhea

⚠️ Warnings 193 words ▾

Warnings Reye´s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behaviour with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye´s syndrome, a rare but serious illness. Allergy alert: Contains salicylate.

Do not take if you are allergic to salicylates (including aspirin) taking other salicylate products Do not use if you have an ulcer a bleeding problem bloody or block stool Ask a doctor before use if you have fever mucus in the stool anticoagulation (thinning the blood) diabetes gout arthritis When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur Stop use and ask a doctor if symptoms get worse or last more than 2 days ringing in the ears or loss of hearing occurs diarrhea lasts more than 2 days If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

🧪 Active Ingredient 11 words ▾

Drug Facts Active ingredient (in each softgel) Bismuth subsalicylate 262 mg

🧪 Inactive Ingredients 24 words ▾

Inactive ingredients Beeswax, Colloidal Silicon Dioxide, Gelatin, Glycerin, Medium Chain Triglycerides, Polysorb, Povidone K-30, Purified Water, Sodium Carboxymethylcellulose, Sorbitol 70%, Soy Lechitin, Titanium Dioxide.

🎯 Purpose 6 words ▾

Purpose Upset stomach reliever and antidiarrheal

📄 Do Not Use 15 words ▾

Do not use if you have an ulcer a bleeding problem bloody or block stool

📄 Ask a Doctor Before Use If 20 words ▾

Ask a doctor before use if you have fever mucus in the stool anticoagulation (thinning the blood) diabetes gout arthritis

📄 When Using This Product 16 words ▾

When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur

📄 Stop Use and Ask a Doctor If 31 words ▾

Stop use and ask a doctor if symptoms get worse or last more than 2 days ringing in the ears or loss of hearing occurs diarrhea lasts more than 2 days

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 28 words ▾

Keep out of reach of children Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Other Information 14 words ▾

Other information store at room temperature 20°-25°C (68°-77°F) Protect from light, heat and moisture

📄 Questions or Comments 3 words ▾

Questions? Visit www.fevia.live

📄 Package Label / Principal Display Panel 41 words ▾

Fevia™ Diarrhea Control Antidiarrheal Fast relief for upset stomach Bismuth Subsalicylate 262 mg 48 SOFTGELS TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR IF SAFETY SEAL UNDER CAP IS BROKEN OR MISSING Sugar Free Actual size PDP PDP interior

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for FEVIA Diarrhea Control (this brand).

Top reported reactions

Nausea93
Vomiting76
Diarrhoea70
Abdominal Pain60
Pain53
Constipation48
Abdominal Distension43

Age at onset

Adolescent2
Adult39
Elderly48

Reporter sex

604 reports
Male · 44%
Female · 56%

Serious outcomes

Hospitalization264
Death125
Life-threatening51
Disabling39
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 54 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by VIVUNT PHARMA LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 24 capsules (82706-0028-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
VIVUNT PHARMA LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 82706-0027-02 · VIVUNT 82706-0029-01 · VIVUNT →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.